ABCL Financial Statements

Balance sheet, income statement, cash flow, and dividends for Abcellera Biologics Inc (ABCL).


$865.42M Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

ABCL Market Cap. (MRY)


ABCL Shares Outstanding (MRY)


ABCL Assets (MRY)


Total Assets

$1.36B

Total Liabilities

$304.47M

Total Investments

$551.59M

ABCL Income (MRY)


Revenue

$28.83M

Net Income

-$162.86M

Operating Expense

$343.60M

ABCL Cash Flow (MRY)


CF Operations

-$108.56M

CF Investing

$121.41M

CF Financing

$12.77M

ABCL Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ABCL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,360,553,000 (-8.57%)

$1,488,094,000 (-3.43%)

$1,540,907,000 (16.86%)

$1,318,569,000 (31.13%)

Assets Current

$751,370,000 (-13.83%)

$871,985,000 (-14.97%)

$1,025,491,000 (10.29%)

$929,800,000 (14.32%)

Assets Non-Current

$609,183,000 (-1.12%)

$616,109,000 (19.54%)

$515,416,000 (32.58%)

$388,769,000 (102.26%)

Goodwill & Intangible Assets

$89,919,000 (-46.55%)

$168,231,000 (-6.18%)

$179,308,000 (-8.61%)

$196,198,000 (33.78%)

Shareholders Equity

$1,056,084,000 (-8.35%)

$1,152,318,000 (-6.56%)

$1,233,277,000 (20.23%)

$1,025,733,000 (23.51%)

Property Plant & Equipment Net

$340,429,000 (18.33%)

$287,696,000 (32.42%)

$217,255,000 (94.65%)

$111,616,000 (522.75%)

Cash & Equivalents

$181,325,000 (14.53%)

$158,320,000 (-61.53%)

$411,535,000 (-17.88%)

$501,142,000 (-15.65%)

Accumulated Other Comprehensive Income

-$4,378,000 (-154.53%)

-$1,720,000 (-23.65%)

-$1,391,000 (-596.79%)

$280,000 (0%)

Deferred Revenue

$19,221,000 (-29.21%)

$27,153,000 (-33.98%)

$41,128,000 (17.69%)

$34,945,000 (7.58%)

Total Investments

$551,586,000 (-20.43%)

$693,203,000 (21.09%)

$572,472,000 (92.66%)

$297,148,000 (1443.87%)

Investments Current

$469,289,000 (-25.18%)

$627,265,000 (25.47%)

$499,950,000 (102.54%)

$246,835,000 (0%)

Investments Non-Current

$82,297,000 (24.81%)

$65,938,000 (-9.08%)

$72,522,000 (44.14%)

$50,313,000 (161.41%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$33,616,000 (9.89%)

$30,590,000 (-20.74%)

$38,593,000 (-75.97%)

$160,576,000 (-24.70%)

Trade & Non-Trade Payables

$63,091,000 (-39.90%)

$104,968,000 (-6.91%)

$112,762,000 (24.72%)

$90,409,000 (60.06%)

Accumulated Retained Earnings (Deficit)

$116,930,000 (-58.21%)

$279,787,000 (-34.35%)

$426,185,000 (59.22%)

$267,666,000 (134.38%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$10,052,000 (-67.16%)

$30,612,000 (-7.73%)

$33,178,000 (-54.58%)

$73,053,000 (17.24%)

Total Debt

$60,743,000 (-14.71%)

$71,222,000 (-7.11%)

$76,675,000 (110.57%)

$36,413,000 (880.16%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$60,743,000 (-14.71%)

$71,222,000 (-7.11%)

$76,675,000 (110.57%)

$36,413,000 (880.16%)

Total Liabilities

$304,469,000 (-9.32%)

$335,776,000 (9.15%)

$307,630,000 (5.05%)

$292,836,000 (67.31%)

Liabilities Current

$76,612,000 (-35.63%)

$119,013,000 (0.59%)

$118,320,000 (-1.95%)

$120,676,000 (16.61%)

Liabilities Non-Current

$227,857,000 (5.12%)

$216,763,000 (14.50%)

$189,310,000 (9.96%)

$172,160,000 (140.66%)

ABCL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$28,833,000 (-24.17%)

$38,025,000 (-92.17%)

$485,424,000 (29.38%)

$375,203,000 (60.92%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$85,490,000 (13.72%)

$75,179,000 (12.62%)

$66,755,000 (36.90%)

$48,761,000 (209.55%)

Research & Development Expense

$167,259,000 (-4.78%)

$175,658,000 (62.83%)

$107,879,000 (73.82%)

$62,062,000 (111.15%)

Operating Expenses

$343,599,000 (24.84%)

$275,232,000 (2.35%)

$268,913,000 (57.45%)

$170,790,000 (121.45%)

Interest Expense

$0 (0%)

$0 (0%)

$4,045,000 (-33.47%)

$6,080,000 (-10.73%)

Income Tax Expense

-$37,538,000 (-35.85%)

-$27,631,000 (-134.29%)

$80,580,000 (22.68%)

$65,685,000 (68.79%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$162,857,000 (-11.24%)

-$146,398,000 (-192.35%)

$158,519,000 (3.29%)

$153,464,000 (29.05%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$162,857,000 (-11.24%)

-$146,398,000 (-192.35%)

$158,519,000 (3.29%)

$153,464,000 (29.05%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$162,857,000 (-11.24%)

-$146,398,000 (-192.35%)

$158,519,000 (3.29%)

$153,464,000 (29.05%)

Weighted Average Shares

$294,327,532 (1.78%)

$289,166,486 (1.44%)

$285,056,606 (3.37%)

$275,763,745 (73.22%)

Weighted Average Shares Diluted

$294,327,532 (1.78%)

$289,166,486 (-8.15%)

$314,827,255 (-1.09%)

$318,294,236 (20.96%)

Earning Before Interest & Taxes (EBIT)

-$200,395,000 (-15.15%)

-$174,029,000 (-171.57%)

$243,144,000 (7.95%)

$225,229,000 (36.80%)

Gross Profit

$28,833,000 (-24.17%)

$38,025,000 (-92.17%)

$485,424,000 (29.38%)

$375,203,000 (60.92%)

Operating Income

-$314,766,000 (-32.70%)

-$237,207,000 (-209.56%)

$216,511,000 (5.92%)

$204,413,000 (31.01%)

ABCL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$121,409,000 (154.91%)

-$221,108,000 (37.30%)

-$352,625,000 (-6.13%)

-$332,247,000 (-177.38%)

Net Cash Flow from Financing

$12,769,000 (23.30%)

$10,356,000 (736.12%)

-$1,628,000 (58.11%)

-$3,886,000 (-100.57%)

Net Cash Flow from Operations

-$108,556,000 (-147.41%)

-$43,877,000 (-115.82%)

$277,360,000 (13.40%)

$244,584,000 (977.94%)

Net Cash Flow / Change in Cash & Cash Equivalents

$23,005,000 (109.06%)

-$254,040,000 (-193.72%)

-$86,492,000 (6.97%)

-$92,974,000 (-115.85%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

-$11,457,000 (86.93%)

Net Cash Flow - Investment Acquisitions and Disposals

$164,097,000 (197.15%)

-$168,912,000 (43.01%)

-$296,399,000 (-0.49%)

-$294,959,000 (-1588.95%)

Capital Expenditure

-$78,396,000 (-1.88%)

-$76,947,000 (-8.90%)

-$70,660,000 (-20.89%)

-$58,452,000 (-504.28%)

Issuance (Repayment) of Debt Securities

$13,498,000 (16.46%)

$11,590,000 (376.56%)

$2,432,000 (118.31%)

$1,114,000 (-98.71%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$2,617,000 (-544.31%)

$589,000 (106.14%)

-$9,599,000 (-573.61%)

-$1,425,000 (0%)

Share Based Compensation

$67,581,000 (5.29%)

$64,183,000 (29.71%)

$49,481,000 (61.46%)

$30,646,000 (264.96%)

Depreciation Amortization & Accretion

$96,998,000 (213.97%)

$30,894,000 (-6.67%)

$33,102,000 (91.90%)

$17,250,000 (227.26%)

ABCL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-564.80% (-46.70%)

-385.00% (-1277.37%)

32.70% (-20.05%)

40.90% (-19.80%)

EBITDA Margin

-358.60% (4.73%)

-376.40% (-761.51%)

56.90% (-11.92%)

64.60% (-11.39%)

Return on Average Equity (ROAE)

-14.90% (-20.16%)

-12.40% (-196.12%)

12.90% (-17.83%)

15.70% (-44.52%)

Return on Average Assets (ROAA)

-11.60% (-19.59%)

-9.70% (-196.04%)

10.10% (-21.71%)

12.90% (-44.16%)

Return on Sales (ROS)

-695.00% (-51.85%)

-457.70% (-1013.57%)

50.10% (-16.50%)

60.00% (-15.01%)

Return on Invested Capital (ROIC)

-18.20% (-15.92%)

-15.70% (-146.59%)

33.70% (-48.47%)

65.40% (-64.42%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-5.33 (52.42%)

-11.2 (-161.89%)

18.09 (-29.16%)

25.54 (-66.37%)

Price to Sales Ratio (P/S)

29.91 (-31.12%)

43.42 (629.92%)

5.95 (-43.40%)

10.51 (-61.75%)

Price to Book Ratio (P/B)

0.82 (-43.05%)

1.44 (-38.81%)

2.35 (-40.14%)

3.93 (-69.53%)

Debt to Equity Ratio (D/E)

0.29 (-1.03%)

0.29 (16.87%)

0.25 (-12.63%)

0.28 (35.07%)

Earnings Per Share (EPS)

-0.55 (-7.84%)

-0.51 (-191.07%)

0.56 (0.00%)

0.56 (5.66%)

Sales Per Share (SPS)

0.1 (-25.19%)

0.13 (-92.31%)

1.7 (25.13%)

1.36 (-7.10%)

Free Cash Flow Per Share (FCFPS)

-0.64 (-51.91%)

-0.42 (-157.66%)

0.72 (7.41%)

0.68 (723.17%)

Book Value Per Share (BVPS)

3.59 (-9.96%)

3.98 (-7.88%)

4.33 (16.29%)

3.72 (-28.69%)

Tangible Assets Book Value Per Share (TABVPS)

4.32 (-5.41%)

4.56 (-4.46%)

4.78 (17.37%)

4.07 (-24.56%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (55.56%)

-9 (-181.82%)

11 (-31.25%)

16 (-75.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-7.54 (29.64%)

-10.72 (-215.13%)

9.31 (-36.14%)

14.58 (-76.66%)

Asset Turnover

0.02 (-20.00%)

0.03 (-91.91%)

0.31 (-1.90%)

0.32 (-30.46%)

Current Ratio

9.81 (33.85%)

7.33 (-15.46%)

8.67 (12.49%)

7.71 (-1.96%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$186,952,000 (-54.73%)

-$120,824,000 (-158.45%)

$206,700,000 (11.05%)

$186,132,000 (1329.91%)

Enterprise Value (EV)

$780,057,200 (-49.17%)

$1,534,635,076 (-40.35%)

$2,572,815,326 (-27.24%)

$3,536,182,232 (-66.69%)

Earnings Before Tax (EBT)

-$200,395,000 (-15.15%)

-$174,029,000 (-172.79%)

$239,099,000 (9.10%)

$219,149,000 (38.85%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$103,397,000 (27.76%)

-$143,135,000 (-151.81%)

$276,246,000 (13.93%)

$242,479,000 (42.71%)

Invested Capital

$1,073,440,000 (-3.62%)

$1,113,752,000 (22.60%)

$908,419,000 (69.18%)

$536,966,000 (225.45%)

Working Capital

$674,758,000 (-10.39%)

$752,972,000 (-17.00%)

$907,171,000 (12.12%)

$809,124,000 (13.99%)

Tangible Asset Value

$1,270,634,000 (-3.73%)

$1,319,863,000 (-3.07%)

$1,361,599,000 (21.31%)

$1,122,371,000 (30.68%)

Market Capitalization

$865,423,200 (-47.77%)

$1,656,872,076 (-42.83%)

$2,898,197,326 (-28.02%)

$4,026,612,232 (-62.37%)

Average Equity

$1,093,764,750 (-7.67%)

$1,184,605,000 (-3.37%)

$1,225,953,000 (25.61%)

$975,983,250 (132.17%)

Average Assets

$1,407,239,500 (-6.73%)

$1,508,842,250 (-3.89%)

$1,569,847,250 (31.60%)

$1,192,920,000 (131.85%)

Invested Capital Average

$1,103,475,500 (-0.35%)

$1,107,387,250 (53.34%)

$722,190,250 (109.73%)

$344,345,750 (284.49%)

Shares

295,366,280 (1.79%)

290,170,241 (1.42%)

286,100,427 (1.60%)

281,581,275 (5.88%)